21272 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#2LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS
#3Compositions and Methods for Treating Alpha-1 Antitrypsin Deficiency
#4METHODS OF SELF-AMPLIFYING RNA-LIPID NANOPARTICLE MANUFACTURE AND COMPOSITIONS DERIVED THEREFROM
#5LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL
#6PREPARATION AND USE OF NUCLEIC ACID WITH ANTI-HAIR LOSS AND OIL CONTROL EFFECTS AND COMPOSITION INCLUDING NUCLEIC ACID
#7LIPOSOMAL FORMULATIONS OF BCL INHIBITORS
#8POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF
#9COMPOUND, PREPARATION METHOD THEREOF, AND LIPID NANOPARTICLE AND PHARMACEUTICAL COMPOSITION
#10LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF
#11LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF
#12PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
#13COMPOSITIONS AND METHODS FOR TREATING DIABETES
#14STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING
#15VESICLES BASED ON GLUCOSE-DERIVED SURFACTANTS AND PHYTOSTEROLS
#16BRILAROXAZINE LIPOSOME COMPOSITION
#17ALPHAXALONE FAT EMULSION INJECTION AND METHOD FOR PREPARING SAME
#18NANOMATERIALS
#19Methods For Treating Pancreatic Cancer Using Combination Therapies
#20COMPOSITIONS AND METHODS FOR TREATING DIABETES
#21LIQUID EPINEPHRINE PRODRUG FORMULATIONS AND LIQUID EPINEPHRINE FORMULATIONS
#22CRYSTALLINE PHARMACEUTICAL COMPOSITION FOR INHALATION COMPRISING SUGAR AND LIPID COMPOSITE PARTICLES AND PROCESS FOR MANUFACTURE
#23CIRCULAR RNA ENCODING CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA
#24FORMULATIONS FOR MODULATING MYC EXPRESSION
#25Branched Tail Lipids and Uses Thereof
#26RNA Particles Comprising Polysarcosine
#27FOLIC ACID-MODIFIED LIPOSOME-ENCAPSULATED TILIANIN NANOCRYSTAL (FA-Lipo@Til NC), PREPARATION METHOD AND USE THEREOF
#28IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF
#29COMPOSITIONS AND METHODS FOR TREATING DIABETES
#30NANOLIPOSOME COMPOSITIONS AND METHODS OF USING THE SAME
#31MANUFACTURING OF BUPIVACAINE MULTIVESICULAR LIPOSOMES
#32COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER
#33AGENTS AND METHODS FOR TREATING DISEASE
#34LIPID NANOPARTICLE (LNP) COMPOSITIONS AND METHODS OF USE THEREOF
#35SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM
#36ON-DEMAND RELEASE OF ANTIBIOTIC COMPOSITION AND METHOD FOR TREATING INFECTIONS
#37COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID
#38TRANSETHOSOME-ENCAPSULATED AGENTS AND METHODS OF USE THEREOF
#39BISPHOSPHONATE LIPIDS, LIPID NANOPARTICLE COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF FOR TARGETED DELIVERY
#40METHODS AND COMPOSITIONS FOR MODULATING FIBRINOGEN
#41COMPOSITIONS AND METHODS FOR PEPTIDE OR PROTEIN DELIVERY TO THE CENTRAL NERVOUS SYSTEM
#42AMINO ACID-BASED CATIONIC LIPID CONTAINING UNSATURATED BONDS
#43Methods and Compositions for Oral Administration of Proteins
#44SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS
#45COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING LIPID NANOPARTICLES
#46ICE-BASED LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF MRNA
#47LIPIDS AND COMPOSITIONS THEREOF
#48ESKETAMINE LIQUID PREPARATION AND USE THEREOF
#49NANOLIPOSOME COMPOSITIONS AND METHODS OF TREATING STROKE
#50PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND USES THEREOF
#51COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#52COMPOSITION FOR LOCALIZED FAT REDUCTION WITHOUT PAIN, EDEMA AND SIDE EFFECTS AND METHOD OF ADMINISTRATION THEREOF
#53ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
#54PROTEIN DELIVERY COMPOSITION CONTAINING BILE SALT AND CATIONIC PEPTIDE AND USE THEREOF
#55TRANSDERMAL CARRIER
#56COMPOSITION FOR INTRAORAL DELIVERY OF BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS
#57COMPOSITIONS AND METHODS FOR TREATING DIABETES
#58COMPOSITIONS AND METHODS FOR TREATING DIABETES
#59LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION
#60Pharmaceutical Composition Of S-Ketamine Hydrochloride
#61PEG LIPIDS AND USES THEREOF
#62COMPOSITIONS COMPRISING STEROL-AMINO-PHOSPHATE COMPOUNDS AND METHODS OF MAKING AND USE THEREOF
#63AMPHIPHILIC TLR7/8 ADJUVANTS AND USES THEREOF
#641H-PYRAZOLE-3-AMINE DERIVATIVE HAVING BICYCLIC BACKBONE
#65PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT
#66COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#67DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
#68DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
#69COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#70SOLID FORMS OF MESEMBRINE AND THERAPEUTIC USES THEREOF
#71DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
#72FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES
#73DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
#74NANOPARTICULATE FORMULATION
#75VARICELLA ZOSTER VIRUS (VZV) VACCINE
#76METHOD OF TREATING OBESITY BY SELECTIVE TARGETING OF VISCERAL ADIPOSITY USING POLYCATION NANOMEDICINE
#77Injectable Suspensions
#78NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS
#79COMPOSITIONS AND METHODS FOR TREATING EPILEPSY
#80LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF
#81LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY
#82INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME
#83COMPOUND AND LIPID COMPOSITION
#84OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF
#85OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF
#86NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#87Therapeutic methods and compositions for treating cancer using devimistat and a fatty acid oxidation inhibitor, a tyrosine kinase inhibitor, a glutaminase inhibitor, and/or a glycolysis inhibitor
#88ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
#89COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#90COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#91PARTICLES OF IMIDAZO[4,5-b]PYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE IN TREATING MEDICAL CONDITIONS
#92COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#93COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#94COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#95COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#96NANOMATERIALS COMPRISING TETRAVALENT LIPID COMPOUNDS
#97ORAL NANOPARTICLES FOR BIOACTIVE COMPOUND, AND METHOD OF PREPARING SAME
#98COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO
#99COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO
#100Methods For Treating Pancreatic Cancer Using Combination Therapies
#101IONIZABLE AMINE AND ESTER LIPIDS AND LIPID NANOPARTICLES
#102NANOMATERIALS COMPRISING DISULFIDES
#103NANOMATERIALS COMPRISING DIAMINES
#104IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES
#105NANOPARTICULATE FORMULATION
#106Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use Thereof
#107LIPID NANOPARTICLES FOR DRUG DELIVERY TO MICROGLIA IN THE BRAIN
#108LIPID NANOPARTICLE SPHERICAL NUCLEIC ACIDS
#109USE OF ST-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT
#110Lipids and compositions thereof
#111MONK FRUIT EXTRACT AND METHOD FOR PRODUCING SAME
#112LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF
#113Epinephrine Pharmaceutical Formulations for Intranasal Delivery
#114Preparation
#115NOVEL LIPOPEPTIDE FORMULATION
#116PERMEATION ENHANCERS FOR GASTROINTESTINAL SYNTHETIC EPITHELIAL LININGS
#117SODIUM DEOXYCHOLATE BILE ACID AS ANTIBIOTIC CARRIER
#118LIPID NANOPARTICLES
#119Application of CB-839 in preparation of drug for inhibiting corneal neovascularization (CNV)
#120BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#121DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
#122KINGLAIT SPORT DRINKS' LINE DESCRIPTION & METHODS OF MANUFACTURING
#123LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF
#124PYRROLO[2,3-D]PYRIMIDIN-2-ONE ANTIMICROBIAL COMPOUNDS
#125CATIONIC LIPIDS AND COMPOSITIONS THEREOF
#126COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#127Nucleic Acid Containing Nanoparticles
#128RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION
#129LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES
#130LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES
#131LIPID COMPOUND OR A DERIVATIVE THEREOF AND PHARMACEUTICAL COMPOSITION EMPLOYING THE SAME
#132CATIONIC LIPIDS AND USES THEREOF
#133PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER
#134SUSTAINED-RELEASE LIPID PRE-CONCENTRATE
#135HDL MIMICKING TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF SOLID TUMORS
#136DEPOT COMPOSITIONS FOR VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) INHBITORS
#137SUGAR-CONJUGATED LIPID NANOPARTICLES AND METHODS OF USE THEREFOR
#138METHODS AND COMPOSITIONS FOR MODULATING PLASMINOGEN
#139RNA INTERFERENCE DELIVERY FORMULATION AND METHODS FOR MALIGNANT TUMORS
#140LIPID NANOPARTICLE WITH TARGET INTEGRIN FUNCTION AND USES THEREOF
#141NOVEL CARBONYL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS
#142Lipid nanoparticle compositions for delivering circular polynucleotides
#143PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
#144ORAL LIPOSOMAL COMPOSITIONS
#145METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING
#146DECOQUINATE LIPOSOME, PREPARATION METHOD THEREFOR AND USE THEREOF
#147UTIDELONE LIPOSOME COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#148NANOLIPID CARRIER BASED FORMULATION FOR BRAIN DELIVERY THROUGH INTRANASAL ROUTE AND ITS PREPARATION PROCESS
#149POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF
#150URSOLIC ACID PREPARATIONS AND USES THEREOF
#151IONIZABLE LIPIDS AND COMPOSITIONS FOR NUCLEIC ACID DELIVERY
#152ANTI-TUMOR AGENT
#153ANTIMICROBIAL DRESSING FOR WOUNDS
#154Compositions having improved bioavailability of therapeutics
#155BIOLOGICAL DELIVERY SYSTEMS
#156CRAC CHANNEL INHIBITOR COMPOSITIONS
#157Circular RNA encoding chimeric antigen receptors targeting BCMA
#158Biodegradable Implant Including Naltrexone and Cholesterol
#159PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF TREPROSTINIL
#160Lipids and compositions for the delivery of therapeutics
#161Compositions and methods for treatment of neurological disorders
#162Process of Preparing mRNA-Loaded Lipid Nanoparticles
#163COMPOSITIONS AND METHODS FOR STABILIZATION OF LIPID NANOPARTICLE MRNA VACCINES
#164FOOD SUPPLEMENT
#165BIOCOMPATIBLE ORGANOGEL MATRICES FOR PREPARATION OF A DRUG DELIVERY DEPOT
#166PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERTENSION
#167TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE
#168Sustained-release anesthetic compositions and methods of preparation thereof
#169PREFERRED ORAL TESTOSTERONE UNDECANOATE THERAPY TO ACHIEVE TESTOSTERONE REPLACEMENT TREATMENT
#170COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#171Methods of manufacturing 14,15-epoxyeicosatrienoic acid analogs and improved therapeutic delivery of same
#172COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT
#173NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#174Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
#175Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#176Amino Lipid and Preparation Method and Application Thereof
#177Nanostructured Gels Capable of Controlled Release of Encapsulated Agents
#178ALTERNATIVE SURFACTANTS AS STABILIZERS FOR THERAPEUTIC PROTEIN FORMULATIONS
#179LIPOSOME COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF AND USE THEREOF IN THERAPY
#180COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS
#181ASYMMETRIC CHARGED VESICLES AND METHODS OF PREPARING AND USE THEREOF
#182PH-RESPONSIVE LIPIDOID NANOPARTICLES FOR INTRACELLULAR MRNA DELIVERY
#183METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF
#184PHOSPHOLIPID
#185Ionizable lipid compounds, lipid nanoparticles comprising same and therapeutic uses thereof
#186Compositions and methods for targeted delivery to cells
#187METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE
#188COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM
#189METHODS OF PREPARING LIPID NANOPARTICLES
#190RAPAMYCIN (RAPA) COMPOSITION AND PREPARATION METHOD THEREOF
#191SONOSENSITIVE LIPOSOME AND METHOD FOR PREPARING SAME
#192ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
#193Safe Use of Bile Acids and Their Salts as Enhancers for Nasal Delivery of Pharmaceuticals
#194METHOD OF PREPARING LOXAPINE FILM ORAL DOSAGE FORM
#195COMPOSITIONS OF BUPIVACAINE MULTIVESICULAR LIPOSOMES
#196Pharmaceutical Composition Of S-Ketamine Hydrochloride
#197RNA MOLECULES
#198Ionizable lipids and compositions for nucleic acid delivery
#199RNA VACCINES
#200Compositions and Methods for Treating Alpha-1 Antitrypsin Deficiency
#201METHODS OF IMAGING AND DELIVERING THERAPEUTIC AGENTS
#202LIPID COMPOSITION
#203COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MAKING THEREOF
#204COMPOSITION OF ANTIVIRAL AGENT FOR USE IN PROPHYLACTIC OR POST-EXPOSURE TREATMENT OF INFECTIOUS OR RESPIRATORY DISEASES
#205Liposomes Useful for Drug Delivery
#206Naloxone Pharmaceutical Formulations for Intranasal (IN) Delivery
#207COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#208COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A SUBJECT FOR THE TREATMENT OF OR REDUCING THE ONSET OF A HEALTH CONDITION
#209CANNABINOID MEDICAL CARRIER
#210CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLATE CELLS
#211LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
#212TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES
#213DOSAGE FORMS FOR IMPROVING ORGAN TRANSPLANTATION, GRAFT VERSUS HOST DISEASE AND STEM CELLS TRANSPLANTS
#214Bupivacaine multivesicular liposome formulations and uses thereof
#215EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF
#216TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES
#217Transdermal carrier
#218Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#219PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES
#220Methods For Treating Pancreatic Cancer Using Combination Therapies
#221POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF
#222Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto
#223COMPOSITIONS, KITS AND METHODS FOR ENHANCING THERAPEUTIC COMPLIANCE
#224LIPOSOMAL FORMULATIONS OF BCL INHIBITORS
#225DELIVERY CARRIER INTO CELL
#226NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEM
#227BLOOD-BRAIN BARRIER PERMEABLE HETERODUPLEX NUCLEIC ACID
#228COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES
#229INFECTIOUS DISEASE VACCINES
#230SUSTAINED RELEASE OF ANTIINFECTIVES
#231Varicella zoster virus (VZV) vaccine
#232Compounds and compositions for intracellular delivery of therapeutic agents
#233STEROL ANALOGS AND USES THEREOF
#234EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF
#235LIPID NANOPARTICLE LYOPHILIZED COMPOSITION
#236FORMULATIONS USING LITHIUM TO TREAT GOUT ARTHROPATHY
#237KRAS VARIANT MRNA MOLECULES
#238METHODS FOR MANUFACTURING AN ADJUVANT
#239COMPOSITIONS OF CANNABINOIDS FOR DELIVERY BY INHALATION
#240LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS
#241LIPOSOMES AND USES THEREOF
#242Compositions Having Improved Bioavailability of Therapeutics
#243Method for preparing a liposomal composition comprising latanoprost, and the pharmacologically active liposomal composition for ophthalmotherapy prepared by this method
#244STABLE COLLOIDAL DRUG AGGREGATES AND METHODS OF MANUFACTURE AND USE THEREOF
#245COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF AGENTS
#246CABAZITAXEL LIQUID FORMULATIONS
#247METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS
#248Compositions of bupivacaine multivesicular liposomes
#249Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#250LIPID COMPOSITION
#2515-heteroaryl-1H-pyrazol-3-amine derivative
#252Vaccine adjuvant formulation
#253PROCESS FOR THE PREPARATION OF ANTHRAQUINONE TOPICAL FORMULATION
#254COMPOSITIONS AND METHODS FOR mRNA DELIVERY
#255SUSTAINED-RELEASE LIPID COMPOSITION AND PREPARATION METHOD THEREFOR
#256Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
#257WATER SOLUBLE ADJUVANT AND COMPOSITION CONTAINING SAME
#258COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MAKING THEREOF
#259METHOD FOR PRODUCTION OF LIPOSOMES
#260METHODS OF LIPID NANOPARTICLE MANUFACTURE AND COMPOSITIONS DERIVED THEREFROM
#261Compositions of bupivacaine multivesicular liposomes
#262COMPOSITIONS FOR SKIN AND WOUNDS AND METHODS OF USE THEREOF
#263ORALLY DELIVERED LIPID NANOPARTICLES TARGET AND REVEAL GUT CD36 AS A MASTER REGULATOR OF SYSTEMIC LIPID HOMEOSTASIS WITH DIFFERENTIAL GENDER RESPONSES
#264IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF
#265IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY
#266Reduction of flake-like aggregation in nanoparticulate active agent compositions
#267INHALABLE SUSTAINED RELEASE COMPOSITION OF BRONCHODILATOR FOR USE IN TREATING PULMONARY DISEASE
#268LIPOSOMAL SUSTAINED-RELEASE COMPOSITIONS CONTAINING A THERAPEUTIC DRUG AND USE THEREOF
#269LIPID PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF
#270METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
#271Carbohydrate conjugates as delivery agents for oligonucleotides
#272INJECTABLE FORMULATIONS
#273Compositions and systems comprising transfection-competent vesicles free of organic-solvents and detergents and methods related thereto
#274SYNTHESIS OF BIOMIMETIC CELL WALL STRUCTURE
#275Composition of docetaxel liposomal injection with high drug loading
#276DRUG-LOADED EMULSION
#277Essential oil emulsion nostril treatment composition
#278PREPARATION METHOD AND USE OF MODIFIED HYDROPHOBIC EXCIPIENT
#279LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL
#280Nano-carrier topical composition with vitamin D3
#281Method for administering liposomal composition
#282Precipitation resistant small molecule drug formulations
#283LIPID COMPOSITION
#284Nanoliposome Compositions And Methods Of Treating Stroke
#285Enhanced Rodeferin Broad Spectrum
#286TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION
#287SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OF A SEDATIVE DRUG AND USES THEREOF
#288Pharmaceutical composition for controlled release of treprostinil
#289PEG lipids and uses thereof
#290Lipid nanoparticles for in-vivo drug delivery, and uses thereof
#291Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
#292POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF
#293Formulations for epidermal repair
#294OPHTHALMIC COMPOSITIONS FOR DELIVERING MEIBUM-LIKE MATERIALS
#295Lipids and compositions for the delivery of therapeutics
#296Anhydrous compositions of mTOR inhibitors and methods of use
#297Carbohydrate conjugates as delivery agents for oligonucleotides
#298RNA Particles Comprising Polysarcosine
#299Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#300Transdermal carrier